Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia.
Gil-Guillen V, Orozco-Beltran D, Redon J, Pita-Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fluixa C, Fernandez A, Martin-Moreno JM, Pascual-de-la-Torre M, Trillo JL, Durazo-Arvizu R, Cooper R, Hermenegildo M, Rosado L. Gil-Guillen V, et al. Among authors: trillo jl. BMC Public Health. 2010 Nov 22;10:717. doi: 10.1186/1471-2458-10-717. BMC Public Health. 2010. PMID: 21092179 Free PMC article.
Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.
Palazón-Bru A, Gil-Guillén VF, Orozco-Beltrán D, Pallarés-Carratalá V, Valls-Roca F, Sanchís-Domenech C, Martín-Moreno JM, Redón J, Navarro-Pérez J, Fernández-Giménez A, Pérez-Navarro AM, Trillo JL, Usó R, Ruiz E. Palazón-Bru A, et al. Among authors: trillo jl. PLoS One. 2014 Mar 13;9(3):e91567. doi: 10.1371/journal.pone.0091567. eCollection 2014. PLoS One. 2014. PMID: 24626597 Free PMC article.
Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.
Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, Pascual de la Torre M, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group. Orozco-Beltran D, et al. Among authors: trillo jl. PLoS One. 2017 Oct 18;12(10):e0186196. doi: 10.1371/journal.pone.0186196. eCollection 2017. PLoS One. 2017. PMID: 29045483 Free PMC article.
Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.
Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, de la Torre MP, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group. Orozco-Beltran D, et al. Among authors: trillo jl. PLoS One. 2018 Sep 27;13(9):e0205047. doi: 10.1371/journal.pone.0205047. eCollection 2018. PLoS One. 2018. PMID: 30261062 Free PMC article.
Multidisciplinary Delphi consensus on challenges and key factors for an optimal care model in chronic kidney disease.
Górriz JL, Alcázar Arroyo R, Arribas P, Artola S, Cinza-Sanjurjo S, la Espriella R, Escalada J, García-Matarín L, Martínez L, Julián JC, Miramontes-González JP, Rubial F, Salgueira M, Soler MJ, Trillo JL. Górriz JL, et al. Among authors: trillo jl. Nefrologia (Engl Ed). 2024 Sep-Oct;44(5):678-688. doi: 10.1016/j.nefroe.2024.09.004. Epub 2024 Nov 5. Nefrologia (Engl Ed). 2024. PMID: 39505678 Free article.
A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries.
Zozaya N, Villaseca J, Fernández I, Abdalla F, Cadenas-Noreña B, Calleja MÁ, Gómez-Pajuelo P, Mestre-Ferrándiz J, Oliva-Moreno J, Trillo JL, Hidalgo-Vega Á. Zozaya N, et al. Among authors: trillo jl. Appl Health Econ Health Policy. 2024 May;22(3):297-313. doi: 10.1007/s40258-023-00867-9. Epub 2024 Jan 12. Appl Health Econ Health Policy. 2024. PMID: 38214848 Review.
Comparison of GLP-1 receptor agonists and other Glucose-Lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and Obesity: A Spanish Real-World Population-Based study.
Palanca A, Ampudia-Blasco FJ, Calderón JM, Sauri I, Martinez-Hervás S, Trillo JL, Redón J, Real JT. Palanca A, et al. Among authors: trillo jl. Diabetes Res Clin Pract. 2024 Jan;207:111071. doi: 10.1016/j.diabres.2023.111071. Epub 2023 Dec 22. Diabetes Res Clin Pract. 2024. PMID: 38142748
22 results